Compare

FamiCord/€V3V

1D1W1M3M6MYTD1Y5YMAX

About FamiCord

Vita 34 AG, founded in 1997 and headquartered in Leipzig, Germany, specializes in the collection, processing, and long-term storage of stem cells from umbilical cord blood and tissue. The company offers cryopreservation services, enabling the storage of perinatal tissues for potential future medical therapies. Following its merger with PBKM, Vita 34 has expanded its focus to include investments in cell and gene therapies, as well as contract development and manufacturing organization (CDMO) services. Operating in approximately 50 countries, the company has stored around one million units of biological material. In 2023, Vita 34 reported revenues of €77.1 million, marking an 11.8% increase from the previous year.
Ticker
€V3V
Sector
Health
Primary listing
XETRA
Employees
684
Headquarters
Leipzig, Germany

FamiCord Metrics

BasicAdvanced
€42M
-
-€0.43
0.62
-

FamiCord Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

FamiCord Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.